Digestive Health

News Watch

Butterflies in your stomach before a big presentation is a familiar experience, but surprisingly, scientists don't yet know exactly how this happens. The gut-brain axis – the brain's influence on the gastrointestinal tract and the other way around – is now a subject of keen scientific interest. A recent review, published in Neuropsychiatric Disease and Treatment, covered what we know…

GMFH Editing Team
GMFH Editing Team

Butterflies in your stomach before a big presentation is a familiar experience, but surprisingly, scientists don't yet know exactly how this happens. The gut-brain axis – the brain's influence on the gastrointestinal tract and the other way around – is now a subject of keen scientific interest. A recent review, published in Neuropsychiatric Disease and Treatment, covered what we know…

GMFH Editing Team
GMFH Editing Team

Digestion is extraordinarily complex, and there is a long list of ways it can go wrong. From constipation to bloating, digestive disorders can cause significant distress for infants and children as they develop. Fortunately, with emerging research on the microbiota, doctors, dietitians, and other healthcare professionals have a growing list of science-based strategies to use in addressing these problems. Healthcare…

GMFH Editing Team
GMFH Editing Team

Digestion is extraordinarily complex, and there is a long list of ways it can go wrong. From constipation to bloating, digestive disorders can cause significant distress for infants and children as they develop. Fortunately, with emerging research on the microbiota, doctors, dietitians, and other healthcare professionals have a growing list of science-based strategies to use in addressing these problems. Healthcare…

GMFH Editing Team
GMFH Editing Team

In this interview, filmed during the 4th Gut Microbiota for Health World Summit, Professor Magnus Simrén of the University of Gothenburg (Sweden) and Chairman of the United European Gastroenterology (UEG) Scientific Committee, explains to Gut Microbiota Worldwatch the relationship between the gut microbiota and irritable bowel syndrome (IBS). The video tells us exactly what irritable bowel syndrome is, what kind of…

GMFH Editing Team
GMFH Editing Team

In this interview, filmed during the 4th Gut Microbiota for Health World Summit, Professor Magnus Simrén of the University of Gothenburg (Sweden) and Chairman of the United European Gastroenterology (UEG) Scientific Committee, explains to Gut Microbiota Worldwatch the relationship between the gut microbiota and irritable bowel syndrome (IBS). The video tells us exactly what irritable bowel syndrome is, what kind of…

GMFH Editing Team
GMFH Editing Team

Abdominal pain, bloating, changes in stool frequency and consistency. These are just some of the symptoms associated with Irritable Bowel Syndrome (IBS), a chronic functional disorder whose origins are unknown. It has no known treatment, only recommendations to keep symptoms at bay. In Western countries, almost two out of ten gastroenterology consultations are motivated by this disorder.   Professor Magnus Simrén, researcher at…

GMFH Editing Team
GMFH Editing Team

Abdominal pain, bloating, changes in stool frequency and consistency. These are just some of the symptoms associated with Irritable Bowel Syndrome (IBS), a chronic functional disorder whose origins are unknown. It has no known treatment, only recommendations to keep symptoms at bay. In Western countries, almost two out of ten gastroenterology consultations are motivated by this disorder.   Professor Magnus Simrén, researcher at…

GMFH Editing Team
GMFH Editing Team

Colorectal cancer (also known as bowel cancer) is the third most common cancer in the world, according to World Cancer Research Fund International. By 2035, it is predicted there will be 2.4 million cases of this type of tumour diagnosed annually worldwide, mostly in developed countries. The risk of developing it is about 1 in 20 (5%) and it is…

GMFH Editing Team
GMFH Editing Team

Colorectal cancer (also known as bowel cancer) is the third most common cancer in the world, according to World Cancer Research Fund International. By 2035, it is predicted there will be 2.4 million cases of this type of tumour diagnosed annually worldwide, mostly in developed countries. The risk of developing it is about 1 in 20 (5%) and it is…

GMFH Editing Team
GMFH Editing Team

Research & Practice

Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder in western societies and recent research has proposed gut microbiota as one of the potential main factors involved. However, little is known regarding the relationship between the composition and function of the gut microbiota and clinical symptoms of IBS. A recent study, led by Prof. Magnus Simrén from the…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder in western societies and recent research has proposed gut microbiota as one of the potential main factors involved. However, little is known regarding the relationship between the composition and function of the gut microbiota and clinical symptoms of IBS. A recent study, led by Prof. Magnus Simrén from the…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Scientific evidence shows probiotics may have a role in treating acute infectious diarrhoea and preventing antibiotic-associated diarrhoea. However, little is known regarding their role in the treatment of diarrhoea generated as a result of radiotherapy or chemotherapy treatments. A recent systematic review and meta-analysis, led by Dr. C-X Pei from The First Clinical Medical College and Evidence Based Medical Centre…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Scientific evidence shows probiotics may have a role in treating acute infectious diarrhoea and preventing antibiotic-associated diarrhoea. However, little is known regarding their role in the treatment of diarrhoea generated as a result of radiotherapy or chemotherapy treatments. A recent systematic review and meta-analysis, led by Dr. C-X Pei from The First Clinical Medical College and Evidence Based Medical Centre…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Crohn’s disease (CD) is a relapsing inflammatory bowel disease that results from a complex interplay between host genetic factors and endogenous microbial communities. Host factors and environmental factors may have effects on the microbiota and possibly initiate inflammation, but then gut dysbiosis may play a role in maintaining this cycle of inflammation. While the vast majority of studies have focused…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Crohn’s disease (CD) is a relapsing inflammatory bowel disease that results from a complex interplay between host genetic factors and endogenous microbial communities. Host factors and environmental factors may have effects on the microbiota and possibly initiate inflammation, but then gut dysbiosis may play a role in maintaining this cycle of inflammation. While the vast majority of studies have focused…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Crohn’s disease (CD) is a chronic inflammatory condition of diverse aetiology in which host genetics and the gut microbiome may interact to regulate susceptibility. People with CD tend to have higher numbers of a type of gut bacteria known as adherent-invasive Escherichia coli (AIEC) in their guts. Besides this, acute infectious gastroenteritis caused by Salmonella or other enteric pathogens, increase…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Crohn’s disease (CD) is a chronic inflammatory condition of diverse aetiology in which host genetics and the gut microbiome may interact to regulate susceptibility. People with CD tend to have higher numbers of a type of gut bacteria known as adherent-invasive Escherichia coli (AIEC) in their guts. Besides this, acute infectious gastroenteritis caused by Salmonella or other enteric pathogens, increase…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Recent research has shown that the effects of pharmacological treatments need to be disentangled from the effects of specific diseases on the human microbiota, as drug therapy effects may be a potential confound in human microbiome studies. However, to what extent drug treatment effectiveness is related to changes in gut microbiota composition and functionality is poorly studied. A recent study,…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Recent research has shown that the effects of pharmacological treatments need to be disentangled from the effects of specific diseases on the human microbiota, as drug therapy effects may be a potential confound in human microbiome studies. However, to what extent drug treatment effectiveness is related to changes in gut microbiota composition and functionality is poorly studied. A recent study,…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados